PubMed:8212965
Annnotations
jnlpba-st-training
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T1 | 13-38 | protein | denotes | transcription factor AP-1 |
| T2 | 63-74 | cell_type | denotes | lymphocytes |
| T3 | 520-538 | protein | denotes | Phytohemagglutinin |
| T4 | 550-561 | cell_type | denotes | lymphocytes |
| T5 | 675-686 | cell_type | denotes | lymphocytes |
| T6 | 818-822 | protein | denotes | AP-1 |
| T7 | 847-862 | cell_type | denotes | NCL lymphocytes |
| T8 | 877-884 | cell_type | denotes | DS ones |
| T9 | 982-993 | cell_type | denotes | fibroblasts |
| T10 | 1041-1052 | cell_type | denotes | lymphocytes |
pubmed-sentences-benchmark
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| S1 | 0-135 | Sentence | denotes | The impaired transcription factor AP-1 DNA binding activity in lymphocytes derived from subjects with some symptoms of premature aging. |
| S2 | 136-263 | Sentence | denotes | The study of human disorders known as premature aging syndromes may provide insight into the mechanisms of cellular senescence. |
| S3 | 264-348 | Sentence | denotes | The main feature of cellular senescence in vitro is cessation of cell proliferation. |
| S4 | 349-519 | Sentence | denotes | Down syndrome (DS) and neuronal ceroid-lypofuscinosis (NCL) are clinically characterized by the premature onset of numerous features normally associated with human aging. |
| S5 | 520-728 | Sentence | denotes | Phytohemagglutinin stimulated lymphocytes derived from DS subjects showed a statistically significant diminished proliferation capacity in comparison with lymphocytes derived from NCL and healthy individuals. |
| S6 | 729-885 | Sentence | denotes | We demonstrated, by applying the electrophoretic mobility shift assay, slightly impaired AP-1 DNA binding activity in NCL lymphocytes and strong in DS ones. |
| S7 | 886-1116 | Sentence | denotes | Our results showed that the same molecular mechanisms of proliferation cessation could exist in fibroblasts characterized by replicative senescence and in lymphocytes derived from individuals with premature aging syndromes (Down). |
genia-medco-coref
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| C1 | 102-134 | NP | denotes | some symptoms of premature aging |
| C2 | 174-199 | NP | denotes | premature aging syndromes |
| C3 | 243-262 | NP | denotes | cellular senescence |
| C4 | 284-312 | NP | denotes | cellular senescence in vitro |
| C5 | 372-408 | NP | denotes | neuronal ceroid-lypofuscinosis (NCL) |
| C6 | 700-703 | NP | denotes | NCL |
| C7 | 851-862 | NP | denotes | lymphocytes |
| C8 | 880-884 | NP | denotes | ones |
| C9 | 1083-1108 | NP | denotes | premature aging syndromes |
| R1 | C2 | C1 | coref-other | premature aging syndromes,some symptoms of premature aging |
| R2 | C4 | C3 | coref-ident | cellular senescence in vitro,cellular senescence |
| R3 | C6 | C5 | coref-ident | NCL,neuronal ceroid-lypofuscinosis (NCL) |
| R4 | C8 | C7 | coref-pron | ones,lymphocytes |
| R5 | C9 | C2 | coref-ident | premature aging syndromes,premature aging syndromes |
GENIAcorpus
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T1 | 4-12 | other_name | denotes | impaired |
| T2 | 13-38 | protein_family_or_group | denotes | transcription factor AP-1 |
| T3 | 63-74 | cell_type | denotes | lymphocytes |
| T4 | 88-96 | multi_cell | denotes | subjects |
| T5 | 119-134 | other_name | denotes | premature aging |
| T6 | 149-164 | other_name | denotes | human disorders |
| T7 | 174-199 | other_name | denotes | premature aging syndromes |
| T8 | 243-262 | other_name | denotes | cellular senescence |
| T9 | 284-303 | other_name | denotes | cellular senescence |
| T10 | 329-347 | other_name | denotes | cell proliferation |
| T11 | 349-362 | other_name | denotes | Down syndrome |
| T12 | 364-366 | other_name | denotes | DS |
| T13 | 372-402 | other_name | denotes | neuronal ceroid-lypofuscinosis |
| T14 | 404-407 | other_name | denotes | NCL |
| T15 | 507-518 | other_name | denotes | human aging |
| T16 | 520-538 | protein_molecule | denotes | Phytohemagglutinin |
| T17 | 550-561 | cell_type | denotes | lymphocytes |
| T18 | 575-586 | multi_cell | denotes | DS subjects |
| T19 | 675-686 | cell_type | denotes | lymphocytes |
| T20 | 700-703 | other_name | denotes | NCL |
| T21 | 708-727 | multi_cell | denotes | healthy individuals |
| T22 | 762-798 | other_name | denotes | electrophoretic mobility shift assay |
| T23 | 809-817 | other_name | denotes | impaired |
| T24 | 818-822 | protein_molecule | denotes | AP-1 |
| T25 | 847-862 | cell_type | denotes | NCL lymphocytes |
| T26 | 877-884 | cell_type | denotes | DS ones |
| T27 | 919-939 | other_name | denotes | molecular mechanisms |
| T28 | 943-966 | other_name | denotes | proliferation cessation |
| T29 | 982-993 | cell_type | denotes | fibroblasts |
| T30 | 1011-1033 | other_name | denotes | replicative senescence |
| T31 | 1041-1052 | cell_type | denotes | lymphocytes |
| T32 | 1083-1108 | other_name | denotes | premature aging syndromes |
| T33 | 1110-1114 | other_name | denotes | Down |